Urinary isoflavonoids and Risk of Type 2 Diabetes: A Prospective Investigation in U.S. Women
View/ Open
Author
Ding, Ming
Franke, Adrian
Rosner, Bernard
Giovannucci, Edward
van Dam, Rob M.
Tworoger, Shelley
Hu, Frank
Sun, Qi
Published Version
https://doi.org/10.1017/S0007114515003359Metadata
Show full item recordCitation
Ding, Ming, Adrian A. Franke, Bernard A. Rosner, Edward Giovannucci, Rob M. van Dam, Shelley S. Tworoger, Frank B. Hu, and Qi Sun. 2015. “Urinary Isoflavonoids and Risk of Type 2 Diabetes: A Prospective Investigation in US Women.” British Journal of Nutrition 114 (10): 1694–1701. https://doi.org/10.1017/s0007114515003359.Abstract
To examine the association between urinary excretion of isoflavonoids and risk of type 2 diabetes (T2D), we conducted a nested case-control study among 1111 T2D pairs identified during 1995-2008 in the Nurses' Health Study (NHS) and NHSII, who were free of diabetes, CVD and cancer at urine sample collection. Urinary excretion of daidzein and genistein, as well as their metabolites O-desmethylangolensin (O-DMA), dihydrogenistein (DHGE) and dihydrodaidzein (DHDE) was assayed using liquid chromatography MS. Self-reported T2D incident cases were confirmed using a validated questionnaire. Higher urinary excretion of daidzein and genistein was associated with a lower risk of T2D in the combined cohorts. Comparing extreme tertiles of the urinary markers, the OR of T2D were 0.71 (95% CI 0.55, 0.93) for daidzein and 0.74 (95% CI 0.56, 0.97) for genistein, although the test for linear trend was not significant for genistein (P-trend=0.03 and 0.15, respectively). DMA, DHDE and DHGE were non-significantly associated with a lower T2D risk. The inverse association of daidzein with T2D risk was stronger among post-menopausal women who did not use hormone replacement therapy (P-interaction=0.001): the OR was 0.58 (95% CI 0.34, 0.97) comparing extreme tertiles among these women. In conclusion, urinary excretion of isoflavones was associated with a lower T2D risk in US women, especially among post-menopausal women who did not use hormone. Further research is warranted to replicate these observations among western populations with similarly low overall isoflavone intake.Terms of Use
This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#OAPCitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41392058
Collections
- SPH Scholarly Articles [6392]
Contact administrator regarding this item (to report mistakes or request changes)